Exploration of Endocrine and Metabolic Diseases

OCT 10, 2026 · JOURNAL ARTICLE

An intelligent systems explanation of type 2 diabetes and a narrative to promote lifestyle change

Exploration of Endocrine and Metabolic Diseases

Type 2 diabetes is an error in the glycemic control system caused by insulin resistance. Self-organizing control systems use artificial intelligence to monitor and correct how they

SEP 23, 2026 · JOURNAL ARTICLE

New avenues in metabolic disease treatment: duodenal mucosal resurfacing and gene therapy

Exploration of Endocrine and Metabolic Diseases

Metabolic diseases including obesity, type 2 diabetes mellitus (T2DM), and metabolic dysfunction-associated steatotic liver disease (MASLD) are increasing rapidly worldwide and con

AUG 13, 2026 · JOURNAL ARTICLE

Glucagon-like peptide 1 receptor agonists in cardiovascular-kidney-metabolic syndrome: a review

Exploration of Endocrine and Metabolic Diseases

A narrative review synthesizing evidence on GLP-1RA mechanisms and effects across cardiometabolic domains, offering clinical perspective rather than reporting original trial data or a systematic quantitative synthesis.